This trial is evaluating whether CRC screening reminder will improve 1 primary outcome and 5 secondary outcomes in patients with Colorectal Cancer. Measurement will happen over the course of 18 months.
This trial requires 2000 total participants across 4 different treatment groups
This trial involves 4 different treatments. CRC Screening Reminder is the primary treatment being studied. Participants will be divided into 4 treatment groups. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"Colon cancer is a highly complex and heterogeneous disease that is caused by combinations of environmental, mechanical, genetic, and other factors. Most likely, colorectal cancer develops as a result of a combination of a number of environmental factors, including age, diet and exercise, obesity, and infections. Colon cancer accounts for more cancer deaths in the western world than any other type of cancer, and the mortality from colon cancer is steadily increasing even in the western world." - Anonymous Online Contributor
"The treatment of [colorectal cancer](https://www.withpower.com/clinical-trials/colorectal-cancer) patients varies significantly across countries that we have surveyed. It appears that in some countries cancer screening programmes using fecal occult blood testing (FOBT) or colonoscopy are recommended for healthy people to detect colorectal cancer at an early stage." - Anonymous Online Contributor
"It is a type of cancer that forms in the colon (bowel ring). A majority of colorectal cancers are diagnosed by colonoscopy.\n\nThe patient encounters an infectious disease and the medical staff and public health officials deal with their illnesses.\n\nAccording to statistics, medical professionals deal with more than 1.4 million infectious diseases, out of which only a quarter are acute. About 5% of all infectious diseases are dangerous. The most common infectious diseases in the Soviet Union were viral and bacterial." - Anonymous Online Contributor
"Colorectal cancer can be highly curable but relapse is common. A cure is possible but is not likely. Patients are advised to be vigilant about their disease-management and the impact of colorectal cancer on their lives must be respected at all stages of the disease, especially if curative treatment is desired." - Anonymous Online Contributor
"Between 726,865 and 735,621 US adults are expected to develop colorectal cancer a year, which is about 1,067 cases/100,000. The colorectal cancer incidence rate is about 6.3/100,000. Thus, about 1 in 25,000 US adults is expected to get colorectal cancer by age 55 if they get colorectal cancer before age 25." - Anonymous Online Contributor
"Changes in bowel habit including loss of faecal urgency and colicky abdominal pain are symptoms of colorectal cancer. Colicky abdominal pain or a change in bowel habit is an early indicator of a colonoscopy is recommended. More importantly, we recommend that people recognise symptoms and be aware of them since this can be a useful way to prevent illness if people early detect that their symptoms aren't being addressed." - Anonymous Online Contributor
"Results from a recent clinical trial are consistent with existing epidemiologic evidence that people at risk for CRC also have the risk factors for developing the cancer. If the findings are confirmed, it will provide additional reason for routine colonoscopy among these individuals." - Anonymous Online Contributor
"We were able to show that it is possible to improve the way in which CRC testing is done by improving communication. If the results of the study are comparable to the national CRC screening rate, we would be able to improve the ways in which CRC is reported and tested in local areas." - Anonymous Online Contributor
"Since CRC screening reminder programs tend to be used, and more than 50 million CRC patients have been screened in the USA, results of prospective randomized trials of strategies to decrease CRC screening errors should be considered first in patients at high risk for CRC." - Anonymous Online Contributor
"This survey clearly demonstrates that there is a large discrepancy between the knowledge, attitudes, and practices of physicians. Knowledge and perceptions of colorectal cancer screening by health care providers are suboptimal; therefore, implementation of evidence-based and standardized protocols may have a positive influence on CRC screening." - Anonymous Online Contributor
"1) Smoking is the major risk factor among those age 50 and older; it accounts for more than 40% of colorectal cancer deaths. Most likely a reflection of cigarette smoking, a risk factor for colorectal cancer has been recognized for a long time. 2) Colonic polyps are a risk factor for colorectal cancer. Colonic polyps are not always detected and it takes time to grow polyps into colorectal cancer. 3) A person with inflammatory bowel disease (e.gs, ulcerative colitis, or Crohn's disease), which is associated with polyps is more than ten times more likely to develop colorectal cancer. 4) Genetic predisposition (e." - Anonymous Online Contributor
"Most common side effects are moderate in severity. The most common symptom is headache which occurs most frequently in women. It tends to be moderate in severity. The most prevalent side effects were moderate in severity. The most commonly encountered symptoms were headache and abdominal pain. The most common side effects of crc screening are fatigue and nausea. They were moderate in severity. Symptoms were reported more frequently in women than men. Symptoms that were more frequently reported were: headache, general weakness and fever in women; dizziness, insomnia, headache and nausea in men. Symptoms that were present in ≥ 50% of participants were: headache, fatigue and general weakness. Symptoms that were present in only 1 to 5% of participants were: insomnia and dizziness." - Anonymous Online Contributor